Duke University
Durham, North Carolina, 27705, United States
NCT Number: NCT05888610
The goal of this clinical trial is to test a mobile application amongst caregiver's supporting patients diagnosed with Alzheimer's Disease and Related Dementias (ADRD). The main question it aims to answer is: Will caregivers supporting patients diagnosed with ADRD utilize a mobile application to routinely report symptoms of the patients they care for?
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Durham, North Carolina, 27705, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A mobile application that allows caregivers of patients diagnosed with Alzheimer's Disease and Related Dementias to report patient symptom remotely to their clinical team.
Time frame: Time Frame up to week 2
Completion of at least 75% of Digital Outpost across 4 days within a 2-week period
Time frame: Time Frame up to week 2
Completion of at least 75% of Clinical Assessments
Time frame: Time Frame 2 weeks
The System Usability Scale will be used for rating technology usability. The measure has 10 items. Each item is measured on a 10-point scale ranging from 0-10. The total score ranges from 0-100, where higher scores indicate greater usability.
Prepped Health LLC
Industry
Identifying Specifications for Caregiver-assisted Solutions to Assess Dementia Patient Needs at Home
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02585232
Alzheimer Disease, Alzheimer's Disease
Tuscaloosa, Alabama, United States
View Trial DetailsNCT00012831
Alzheimer Disease, Alzheimer's Disease
Minneapolis, Minnesota, United States
View Trial DetailsNCT00149175
Alzheimer Disease, Alzheimer's Disease
Caen, France
View Trial DetailsNCT04426539
Alzheimer Disease, Alzheimer's Disease
Philadelphia, Pennsylvania, United States
View Trial Details